Inventor
GILL ADRIAN LIAM
GB22 patents
⚠️ This page may combine multiple inventors who share the name “GILL ADRIAN LIAM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BERDINI VALERIO
7 patentsUS8399442B2Mar 19, 2013
Pharmaceutical compounds
BERDINI VALERIO62 citations95
US8895745B2Nov 25, 2014
Bicyclic heterocyclic compounds as FGFR inhibitors
BERDINI VALERIO33 citations92
US8110573B2Feb 7, 2012
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
BERDINI VALERIO9 citations83
US8513276B2Aug 20, 2013
Imidazo[1,2-a]pyridine compounds for use in treating cancer
BERDINI VALERIO8 citations82
US8080666B2Dec 20, 2011
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO6 citations73
US8779147B2Jul 15, 2014
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
BERDINI VALERIO2 citations62
US8778936B2Jul 15, 2014
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
BERDINI VALERIO2 citations62
ASTEX THERAPEUTICS LTD
5 patentsUS7385059B2Jun 10, 2008
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD33 citations95
US7977477B2Jul 12, 2011
Benzimidazole derivatives and their use as protein kinase inhibitors
ASTEX THERAPEUTICS LTD35 citations92
US7745638B2Jun 29, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD8 citations83
US7825140B2Nov 2, 2010
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD7 citations73
US9051278B2Jun 9, 2015
3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
ASTEX THERAPEUTICS LTD0 citations51
REVOLUTION MEDICINES INC
5 patentsUS10980889B1Apr 20, 2021
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC8 citations81
US12187746B2Jan 7, 2025
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11685749B2Jun 27, 2023
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11702411B2Jul 18, 2023
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US11673901B2Jun 13, 2023
Polycyclic compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations47